Ataxin-3 (ATXN3) <div class="infobox" style="float:right; background:#f8f9fa; border:1px solid #ddd; padding:10px; margin:0 0 10px 10px; width:280px;"> <h3 style="margin-top:0; border-bottom:1px solid #ddd;">Ataxin-3 / ATXN3</h3> <ul style="list-style:none; padding:0; margin:5px 0;"> <li><strong>UniProt:</strong> [P54252](https://www.uniprot.org/uniprot/P54252)</li> <li><strong>Gene:</strong> [ATXN3](/entities/atxn3)</li> <li><strong>Aliases:</strong> AT3, SCA3, MJD, MJD1a</li> <li><strong>MW:</strong> ~42 kDa (varies with polyQ length)</li> <li><strong>Localization:</strong> Nucleus, cytoplasm</li> <li><strong>PDB:</strong> [2L86](https://www.rcsb.org/structure/2L86)</li> </ul> </div>
Overview
...
Ataxin-3 (ATXN3) <div class="infobox" style="float:right; background:#f8f9fa; border:1px solid #ddd; padding:10px; margin:0 0 10px 10px; width:280px;"> <h3 style="margin-top:0; border-bottom:1px solid #ddd;">Ataxin-3 / ATXN3</h3> <ul style="list-style:none; padding:0; margin:5px 0;"> <li><strong>UniProt:</strong> [P54252](https://www.uniprot.org/uniprot/P54252)</li> <li><strong>Gene:</strong> [ATXN3](/entities/atxn3)</li> <li><strong>Aliases:</strong> AT3, SCA3, MJD, MJD1a</li> <li><strong>MW:</strong> ~42 kDa (varies with polyQ length)</li> <li><strong>Localization:</strong> Nucleus, cytoplasm</li> <li><strong>PDB:</strong> [2L86](https://www.rcsb.org/structure/2L86)</li> </ul> </div>
Overview
Mermaid diagram (expand to render)
Ataxin-3 (ATXN3) , also known as Machado-Joseph disease protein , is a cysteine protease deubiquitinase (DUB) that cleaves polyubiquitin chains and regulates protein degradation. CAG repeat expansion in ATXN3 causes Spinocerebellar Ataxia Type 3 (SCA3) , also known as Machado-Joseph disease (MJD) , the most common dominant spinocerebellar ataxia worldwide.[@kawaguchi1994]
Structure and Domains Ataxin-3 contains:
Josephin domain — catalytic domain with deubiquitinase activity (N-terminal)
Polyglutamine tract — CAG repeat region (normal <44; pathogenic >52)
Ubiquitin-interacting motifs (UIMs) — typically 2-3 UIMs that bind ubiquitin chains
Nuclear localization signal — regulates subcellular distribution
The Josephin domain adopts a papain-like fold and contains the catalytic cysteine (C14) and histidine (H158) residues required for deubiquitinase activity.[@mao2005]
Normal Function
Deubiquitinase Activity Ataxin-3 functions as a ubiquitin-specific protease:
Polyubiquitin chain cleavage — Preferentially cleaves K63-linked chains
Chain editing — Converts K63 to K48 linkages for proteasomal targeting
Ubiquitin homeostasis — Maintains cellular ubiquitin pools
DNA Repair Ataxin-3 participates in DNA damage response:[@burnett2006]
Transcription-coupled repair — Interacts with RAD23 proteins
Histone modification — Deubiquitinates histones at damage sites
Genome stability — Protects against DNA damage accumulation
Protein Quality Control
ER-associated degradation (ERAD) — Facilitates clearance of misfolded proteins
Aggresome formation — Regulates trafficking of aggregated proteins
Chaperone interactions — Associates with HSP70 and HSP40
Role in Neurodegeneration
SCA3/Machado-Joseph Disease CAG expansion causes SCA3 through:[@schmidt2019]
Protein Aggregation
Nuclear inclusions — Mutant ataxin-3 forms intranuclear aggregates
Ubiquitin-positive inclusions — Contain ubiquitin, proteasome components
Sequestration — Wild-type ataxin-3 and other proteins trapped in inclusions
Loss of Deubiquitinase Function
Impaired ubiquitin recycling — Reduced proteasome efficiency
Defective DNA repair — Accumulation of DNA damage in [neurons](/entities/neurons)
ERAD dysfunction — Misfolded protein accumulation
Clinical Features SCA3 is characterized by:
Progressive ataxia — Gait and limb incoordination
Ophthalmoplegia — Eye movement abnormalities
Peripheral neuropathy — Sensory and motor deficits
Parkinsonism — Extrapyramidal features in some patients
Pyramidal signs — Spasticity and hyperreflexia
Selective Vulnerability Neuronal populations affected include:
Pontine nuclei
Substantia nigra
Dentate nucleus
Inferior olive
Spinal motor neurons
Therapeutic Targeting
Antisense Oligonucleotides
ATXN3 ASOs — Reduce mutant protein expression
Allele-selective approaches — Target expanded allele specifically
Deubiquitinase Modulation | Strategy | Mechanism | Status | |----------|-----------|--------| | DUB activators | Enhance residual activity | Preclinical | | Ubiquitin mimetics | Boost degradation | Discovery | | Proteostasis enhancers | Improve clearance | Preclinical |
Gene Therapy
AAV-miRNA — Knockdown of ATXN3 expression
CRISPR editing — Targeting CAG repeat expansion
Protein Interactions | Partner | Function | Disease Relevance | |---------|----------|-------------------| | RAD23A/B | DNA repair | Nucleotide excision repair | | VCP/p97 | ERAD | Protein degradation | | HHR23A | DNA repair | Genome stability | | Ubiquitin | Substrate | Deubiquitinase activity |
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[UniProt: P54252](https://www.uniprot.org/uniprot/P54252)
[PDB structures](https://www.rcsb.org/search?q=uniprot:P54252)
References
[Kawaguchi Y, et al, CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 (1994)](https://doi.org/10.1038/ng0894-221)
[Mao Y, et al, Crystal structure of the Josephin domain of ataxin-3 (2005)](https://doi.org/10.1038/sj.emboj.7600300)
[Burnett B, et al, DNA damage is a pathogenic trigger for ataxin-3 in Drosophila models of SCA3 (2006)](https://doi.org/10.1093/hmg/ddl430)
[Schmidt T, et al, Protein surveillance and quality control in SCA3 (2019)](https://doi.org/10.1007/s00401-019-02061-2)
Pathway Diagram The following diagram shows the key molecular relationships involving Ataxin-3 (ATXN3) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description